![Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis | Reumatología Clínica Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis | Reumatología Clínica](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2173574313001378:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9184xd8ym1IgxXJ6I4p31f1upH6Ra9/FExf9t4wRA9EIugkiRkHRaJE9N14iLd8D11ZbYOZ1ibcz7WQ9vBcTEpsn6lDg0+Z4mgtqoJbPRsSBAtn3VCwqxhKOZW1xa/TQXtyfukfIEENKoqVJRNVKC1ttbFXQOfnruggfuAmJ0lyBiyUQIUmQRekP5/xMytnUul0vTVJN0jdccxZjZE09d4w8EpoCHvmeM+YzOMpJ4XuZmlshC8YMXxtMG6/Hx2K4nBXrJvrADbuO8/7dO+XRM5s=)
Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis | Reumatología Clínica
![Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease](https://www.mdpi.com/life/life-11-01375/article_deploy/html/images/life-11-01375-g001.png)
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
![A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-95920-9/MediaObjects/41598_2021_95920_Fig1_HTML.png)
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis | Scientific Reports
![Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrgastro.2013.253/MediaObjects/41575_2014_Article_BFnrgastro2013253_Fig1_HTML.jpg)
Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
Clinical Specialist Services Care Group Department of Pathology - Immunology ADALIMUMAB MONITORING Includes: Serum adalimumab, a
![Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine](https://www.thelancet.com/cms/attachment/c74b52d1-ea65-44cf-a936-74af326c8eaf/gr1_lrg.jpg)
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
![Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics](https://www.frontiersin.org/files/MyHome%20Article%20Library/221738/221738_Thumb_400.jpg)
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
![Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog](https://www.euroimmunblog.de/wp-content/uploads/2020/11/Effects-of-MAb.jpg)